CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Anixa Biosciences, Inc. - ANIX CFD

2.99
0.67%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.23
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 2.97
开盘价* 2.94
1 年变化* -1.67%
日范围* 2.9 - 3.04
52 周范围 2.50-6.25
平均交易量（10 天） 64.75K
平均交易量（3 个月) 1.10M
市值 143.18M
市盈率 -100.00K
流通股 30.92M
收入 N/A
EPS -0.40
股息（收益率 %） N/A
贝塔 0.96
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Jun 29, 2022 2.99 0.05 1.70% 2.94 3.08 2.90
Jun 28, 2022 2.97 -0.04 -1.33% 3.01 3.14 2.95
Jun 27, 2022 3.16 0.15 4.98% 3.01 3.19 3.01
Jun 24, 2022 3.04 0.07 2.36% 2.97 3.12 2.97
Jun 23, 2022 3.13 0.11 3.64% 3.02 3.19 3.02
Jun 22, 2022 3.18 0.21 7.07% 2.97 3.18 2.97
Jun 21, 2022 3.08 0.06 1.99% 3.02 3.19 3.02
Jun 17, 2022 3.00 -0.16 -5.06% 3.16 3.16 2.96
Jun 16, 2022 3.10 0.15 5.08% 2.95 3.18 2.90
Jun 15, 2022 3.08 0.29 10.39% 2.79 3.15 2.79
Jun 14, 2022 2.88 -0.18 -5.88% 3.06 3.09 2.82
Jun 13, 2022 3.07 -0.18 -5.54% 3.25 3.31 3.04
Jun 10, 2022 3.33 -0.10 -2.92% 3.43 3.48 3.27
Jun 9, 2022 3.48 0.07 2.05% 3.41 3.68 3.41
Jun 8, 2022 3.50 0.23 7.03% 3.27 3.54 3.27
Jun 7, 2022 3.38 -0.49 -12.66% 3.87 3.91 3.30
Jun 6, 2022 3.92 -0.27 -6.44% 4.19 4.44 3.87
Jun 3, 2022 3.94 0.16 4.23% 3.78 3.96 3.61
Jun 2, 2022 3.81 0.01 0.26% 3.80 3.85 3.74
Jun 1, 2022 3.69 0.18 5.13% 3.51 3.70 3.37

Anixa Biosciences, Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0 0.5125 0 0.25 1.1125
收入 0 0.5125 0 0.25 1.1125
总营业费用 13.875 13.6482 9.9782 12.14 15.4016
销售/一般/行政费用，总计 7.172 7.0735 5.597 5.66283 6.91183
研究与开发 6.703 6.18969 4.38121 5.47343 6.81304
Depreciation / Amortization 0 0.41875 0.3253
异常费用（收入） 0 0.385 0 0.585 1.35139
Other Operating Expenses, Total
营业收入 -13.875 -13.1357 -9.9782 -11.89 -14.2891
利息收入（费用），非经营净值 0.104 0.00232 0.03392 0.07135 0.04597
税前净收入 -13.771 -13.1279 -10.0924 -11.8187 -14.2431
税后净收入 -13.771 -13.1279 -10.0924 -11.8187 -14.2431
未计算非常项目前的净收益 -13.595 -12.9544 -10.0184 -11.647 -13.996
净收入 -13.595 -12.9544 -10.0184 -11.647 -13.996
普通股股东可获收益 (不含非经常性项目) -13.595 -12.9544 -10.0184 -11.647 -13.996
普通股股东可获收益 (含非經常性項目) -13.595 -12.9544 -10.0184 -11.647 -13.996
摊薄净收入 -13.595 -12.9544 -10.0184 -11.647 -13.996
摊薄后加权平均股 30.374 28.5789 22.229 19.7898 17.6243
扣除特别项目的每股摊薄盈利 -0.44759 -0.45329 -0.45069 -0.58854 -0.79413
Dividends per Share - Common Stock Primary Issue
每股正常摊薄盈利 -0.44759 -0.44 -0.44403 -0.55898 -0.71745
Total Adjustments to Net Income 0
少数股东权益 0.176 0.17352 0.07401 0.1716 0.24706
Gain (Loss) on Sale of Assets 0 0.00545 -0.14808
Oct 2022 Jul 2022 Apr 2022 Jan 2022 Oct 2021
总收入 0 0 0 0 0
收入 0 0 0 0 0
总营业费用 3.609 2.797 3.589 3.88 4.07704
销售/一般/行政费用，总计 1.924 1.352 1.854 2.042 1.9038
研究与开发 1.685 1.445 1.735 1.838 2.17324
异常费用（收入） 0 0 0 0 0
营业收入 -3.609 -2.797 -3.589 -3.88 -4.07704
利息收入（费用），非经营净值 0.08 0.022 0.001 0.001 0.00055
税前净收入 -3.529 -2.775 -3.588 -3.879 -4.07105
税后净收入 -3.529 -2.775 -3.588 -3.879 -4.07105
少数股东权益 0.053 0.029 0.044 0.05 0.05778
未计算非常项目前的净收益 -3.476 -2.746 -3.544 -3.829 -4.01327
净收入 -3.476 -2.746 -3.544 -3.829 -4.01327
普通股股东可获收益 (不含非经常性项目) -3.476 -2.746 -3.544 -3.829 -4.01327
普通股股东可获收益 (含非經常性項目) -3.476 -2.746 -3.544 -3.829 -4.01327
摊薄净收入 -3.476 -2.746 -3.544 -3.829 -4.01327
摊薄后加权平均股 30.764 30.451 30.152 30.125 30.0451
扣除特别项目的每股摊薄盈利 -0.11299 -0.09018 -0.11754 -0.1271 -0.13357
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.11299 -0.09018 -0.11754 -0.1271 -0.13376
Gain (Loss) on Sale of Assets 0 0.00545
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 36.0034 9.36862 6.09312 5.53837 7.01394
现金和短期投资 35.7279 9.05706 5.84163 5.05589 6.83937
现金等价物 29.1283 6.41706 3.49163 3.05589 3.33937
短期投资 6.5996 2.64 2.35 2 3.5
Prepaid Expenses 0.27556 0.30933 0.18497 0.17549 0.17457
Total Assets 36.2574 9.45296 6.29369 6.44854 8.81242
Property/Plant/Equipment, Total - Net 0.25396 0.05434 0.20057 0.07267 0.0527
Property/Plant/Equipment, Total - Gross 0 0.29558 0.12647 0.08843
Accumulated Depreciation, Total 0 -0.09502 -0.0538 -0.03573
Intangibles, Net 0 0.8375 1.74578
Total Current Liabilities 1.27053 1.18859 1.48132 1.26511 0.88949
Accounts Payable 0.1362 0.23237 0.58582 0.58201 0.48032
Accrued Expenses 1.13433 0.95622 0.8955 0.6831 0.40917
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 0.8201 0.69161 1.05834 1.01373 0.88949
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.22008 0
Total Equity 35.4373 8.76136 5.23535 5.43481 7.92292
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.30051 0.24249 0.20332 0.18909 0.16603
Additional Paid-In Capital 239.927 200.354 186.849 175.416 163.931
Retained Earnings (Accumulated Deficit) -204.79 -191.836 -181.817 -170.17 -156.174
Total Liabilities & Shareholders’ Equity 36.2574 9.45296 6.29369 6.44854 8.81242
Total Common Shares Outstanding 30.0509 24.2487 20.3318 18.9086 16.6028
Total Preferred Shares Outstanding 0 0 0 0 0
应收账款总额，净额 0.00223 0.06653 0.30699
Accounts Receivable - Trade, Net 0.00223 0.06653 0.30699
Minority Interest -0.67051 -0.49698 -0.42298 -0.25138
Other Long Term Assets, Total 0 0.03
Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
流动资产总额 32.563 34.994 36.0034 37.052 38.472
现金和短期投资 32.231 34.53 35.7279 36.622 38.1027
现金等价物 27.732 29.781 29.1283 27.2222 27.7034
短期投资 4.499 4.749 6.5996 9.39978 10.3993
Prepaid Expenses 0.332 0.464 0.27556 0.43001 0.36921
Total Assets 32.797 35.238 36.2574 37.0624 38.4975
Property/Plant/Equipment, Total - Net 0.234 0.244 0.25396 0.01041 0.02557
Other Long Term Assets, Total 0 0 0
Total Current Liabilities 1.189 1.787 1.27053 1.20802 1.44287
Accounts Payable 0.093 0.504 0.1362 0.20773 0.43801
Accrued Expenses 1.096 1.283 1.13433 1.00029 1.00486
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 0.626 1.275 0.8201 0.5953 0.88376
Total Long Term Debt 0 0 0 0 0
Minority Interest -0.765 -0.721 -0.67051 -0.61273 -0.55911
Total Equity 32.171 33.963 35.4373 36.4671 37.6138
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.302 0.301 0.30051 0.2995 0.3145
Additional Paid-In Capital 244.032 242.281 239.927 236.944 233.742
Retained Earnings (Accumulated Deficit) -212.163 -208.619 -204.79 -200.777 -196.443
Total Liabilities & Shareholders’ Equity 32.797 35.238 36.2574 37.0624 38.4975
Total Common Shares Outstanding 30.1547 30.1323 30.0509 29.9499 31.4499
Other Liabilities, Total 0.202 0.209 0.22008
Total Preferred Shares Outstanding 0
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -13.1279 -10.0924 -11.8187 -14.2431 -5.00899
经营活动产生的现金 -4.93688 -6.17567 -4.74143 -4.2734 -3.79671
经营活动产生的现金 0 0.03828 0.04756 0.01844 0.04322
Amortization 0 0.41875 0.3253 0.3253
非现金物品 8.1125 4.33743 6.1325 9.55825 0.43553
营运资金的变化 0.07855 -0.45901 0.47842 0.0677 0.40824
投资活动产生的现金 -3.91768 -0.30579 -0.52546 1.4616 -2.73519
资本支出 0 -0.01579 -0.17546 -0.0384 -0.03019
其他投资现金流量项目，总计 -3.91768 -0.29 -0.35 1.5 -2.705
融资活动产生的现金 31.5658 9.4069 5.70262 2.52832 7.38295
融资现金流项目 0.01403 0
股票的发行（报废），净额 31.5658 9.4069 5.68858 2.52832 10.3829
现金净变化 22.7112 2.92544 0.43574 -0.28348 0.85105
已付现金利息 0.00182 0.03989 0 0.27243
债务的发行（退还），净额 0 -3
Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
Net income/Starting Line -7.467 -3.879 -13.1279 -9.05688 -4.66927
Cash From Operating Activities -3.503 -1.197 -4.93688 -3.89271 -2.41195
Cash From Operating Activities 0 0 0
Non-Cash Items 4.12 2.364 8.1125 5.26318 2.06069
Cash Interest Paid 2 1 0.00182 0.00168 0.0014
Changes in Working Capital -0.156 0.318 0.07855 -0.09901 0.19663
Cash From Investing Activities 2.1 1.85 -3.91768 -6.72434 -7.72385
Capital Expenditures 0 0 0
Other Investing Cash Flow Items, Total 2.1 1.85 -3.91768 -6.72434 -7.72385
Cash From Financing Activities 0.007 0 31.5658 31.4222 31.4222
Financing Cash Flow Items 0 -2.54893 -2.54893
Issuance (Retirement) of Stock, Net 0.007 0 31.5658 33.9711 33.9711
Net Change in Cash -1.396 0.653 22.7112 20.8051 21.2864
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.2268 1307142 7144 2022-12-31 LOW
Titterton (Lewis H Jr) Individual Investor 2.5031 774070 0 2023-01-17 LOW
UBS Financial Services, Inc. Investment Advisor 2.0131 622544 853 2022-12-31 LOW
Kumar (Amit) Individual Investor 1.4943 462100 0 2023-01-17 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9353 289238 -2985 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.887 274289 3626 2022-12-31 LOW
Long Focus Capital Management LLC Hedge Fund 0.5358 165701 0 2022-12-31 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3302 102100 0 2022-12-31 LOW
Baskies (Arnold M) Individual Investor 0.3234 100000 0 2023-01-17 LOW
Susquehanna International Group, LLP Investment Advisor 0.2297 71023 31115 2022-12-31 MED
Raymond James & Associates, Inc. Research Firm 0.185 57217 -3629 2022-12-31 LOW
Newton Investment Management North America, LLC Investment Advisor 0.179 55350 0 2022-12-31 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1777 54948 0 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.1582 48925 -714 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1549 47900 -9300 2022-12-31 HIGH
Citadel Advisors LLC Hedge Fund 0.1536 47506 27896 2022-12-31 HIGH
Gottschalk (Emily) Individual Investor 0.1477 45665 0 2023-01-17 LOW
BNY Mellon Asset Management Investment Advisor 0.1367 42268 -238 2022-12-31 LOW
Cambridge Investment Research Advisors, Inc. Investment Advisor 0.1297 40100 25100 2022-12-31 LOW
Corecap Advisors Inc Investment Advisor/Hedge Fund 0.1171 36209 -1177 2022-12-31 MED

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Anixa Biosciences, Inc. Company profile

关于 Anixa Biosciences Inc.

Anixa Biosciences, Inc.是一家生物技术公司。 公司正在开发专注于肿瘤学和传染病的疗法和疫苗。 公司正在开发嵌合内分泌受体T细胞技术，一种专注于治疗卵巢癌的嵌合抗原受体T细胞（CAR-T）技术，以及用于治疗COVID-19的抗病毒候选药物，重点是抑制病毒的某些病毒蛋白功能。 它还在开发针对三阴性乳腺癌（TNBC）的疫苗，这是乳腺癌的致命形式，以及针对卵巢癌的疫苗。 其CAR-T技术可用于治疗多种实体瘤类型。 公司的业务包括CAR-T疗法、癌症疫苗、抗病毒疗法、癌症诊断活动和专利许可活动。 其子公司Curety Therapeutics, Inc.（Curety）正在开发针对癌症的免疫治疗药物。

Industry: Biotechnology & Medical Research (NEC)

3150 Almaden Expy Ste 250
SAN JOSE
CALIFORNIA 95118
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

73.85 Price
+0.310% 1D Chg, %
多头隔夜费 -0.0153%
空头隔夜费 -0.0066%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.55 Price
+3.800% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00517

US100

12,694.00 Price
+0.500% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

BTC/USD

28,066.75 Price
+2.640% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易